The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Wnt/Beta-Catenin/Tcf Signaling: A Critical Pathway in Gastrointestinal Tumorigenesis
Open accessAbstract
Cancers of the gastrointestinal tract, including the liver, bile ducts, and pancreas, constitute the largest group of malignant tumors. Colorectal cancer is one of the most common neoplastic diseases in Western countries and one of the leading causes of cancer-related deaths. Inactivation of the adenomatous polyposis coli (APC) tumor-suppressor gene during early adenoma formation is thought to be the first genetic event in the process of colorectal carcinogenesis followed by mutations in oncogenes like K-Ras and tumor-suppressor genes like p53. Identification of the interaction of APC with the proto-oncogene β-catenin has linked colorectal carcinogenesis to the Wnt-signal transduction pathway. The main function of APC is thought to be the regulation of free β-catenin in concert with the glycogen synthase kinase 3β (GSK-3β) and Axin proteins. Loss of APC function, inactivation of Axin or activating β-catenin mutations result in the cellular accumulation of β-catenin. Upon translocation to the nucleus β-catenin serves as an activator of T-cell factor (Tcf)-dependent transcription leading to an increased expression of several specific target genes including c-Myc, cyclin D1, MMP-7, and ITF-2. While APC mutations are almost exclusively found in colorectal cancers, deregulation of Wnt/β-catenin/Tcf signaling is also common in other gastrointestinal and extra-gastrointestinal human cancers. In a fraction of hepatocellular carcinomas the Wnt pathway is deregulated by inactivation of Axin or stabilizing mutations of β-catenin. The majority of hepatoblastomas and a group of gastric cancers also carry β-catenin mutations. Clearly, this pathway harbors great potential for future applications in cancer diagnostics, staging, and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–212 of 212
The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
Erisman, Scott, J. K., Ra, W., & Astrin, S. M. (1988) · PubMed · Cited by 54
Imaseki, H., Hayashi, H., Taira, M., Ito, Y., Tabata, Y., Onoda, S., Isono, K., & Tatibana, M. (1989) · Cancer · Cited by 50
Choi, Y. W., Heath, E. I., Heitmiller, R. F., Forastiere, A. A., & Wu, T. (2000) · Modern Pathology · doi:10.1038/modpathol.3880194 · Cited by 50
A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene.
Shitoh, K., Konishi, F., Iijima, T., Ohdaira, T., Sakai, K., Kanazawa, K., & Miyaki, M. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.9.695 · Cited by 49
Identification of two novel regulated serines in the N terminus of beta-catenin.
van Noort, M., Wetering, M. L. V. D., & Clevers, H. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5520 · Cited by 48
Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
Chen, R., & McCormick, F. (2001) · PubMed · Cited by 45
Kawasoe, T., Furukawa, Y., Daigo, Y., Nishiwaki, T., Ishiguro, H., Fujita, M., Sato, S., Miwa, N., Nagasawa, Y., Miyoshi, Y., et al. (2000) · PubMed · Cited by 37
Wijnhoven, B. P. L., Nollet, F., Both, N. J. D., Tilanus, H. W., & Dinjens, W. N. M. (2000) · International Journal of Cancer · Cited by 30
Pilomatricomas contain activating mutations in ?-catenin*
Chan, E. F. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)70339-2 · Cited by 30
Wnt signaling: The Naked truth?
McEwen, D. G., & Peifer, M. A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00310-4 · Cited by 21
Activation but Not Inactivation of theMTS1Gene Is Associated with Primary Colorectal Carcinomas
Ohhara, M., Esumi, M., & Kurosu, Y. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1430 · Cited by 20
(1999) · doi:10.1002/(sici)1521-1878(199912)22:1<1021::aid-bies6>3.0.co;2-p
Cited by
Expression Pattern of Wnt Signaling Components in the Adult Intestine
GREGORIEFF, A., PINTO, D., BEGTHEL, H., DESTREE, O., KIELMAN, M., & CLEVERS, H. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.06.007 · Cited by 614
Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer
Dhawan, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24543 · Cited by 566
Joanito, I., Wirapati, P., Zhao, N., Nawaz, Z., Yeo, G., Lee, F., Eng, C. L. P., Macalinao, D. C., Kahraman, M., Srinivasan, H., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01100-4 · Cited by 434
Corvinus, F. M., Orth, C., Moriggl, R., Tsareva, S. A., Wagner, S., Pfitzner, E. B., Baus, D., Kaufman, R., Huber, L. A., Zatloukal, K., et al. (2005) · Neoplasia · doi:10.1593/neo.04571 · Cited by 427
Cyclooxygenase-2 (COX-2)–Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors
Grösch, S., Maier, T. J., Schiffmann, S., & Geisslinger, G. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj206 · Cited by 400
Metadata
- Authors
- Kolligs, F. T., Bommer, G., & Göke, B.
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2002
- Volume
- 66
- Issue
- 3
- Pages
- 131-144
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- OpenAlex
- W1985516721
- Cited by
- 311
- References
- 212
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.